Titration schedule planner

GLP-1 Titration Schedule Planner

Generate a personalized week-by-week titration calendar for any GLP-1 medication using the exact dose-escalation schedule from each drug's FDA Prescribing Information. Select your medication, choose a start date, and optionally indicate your current dose to see only the remaining schedule.

MedicationStart date

I'm already on a dose — show only the remaining schedule

Important: Your prescriber may adjust this schedule based on your tolerance. This is the standard FDA-label protocol — do not change doses without medical guidance. If side effects are intolerable at any step, contact your prescriber before the next increase.

Wegovy (semaglutide 2.4 mg) — titration calendar

Maintenance dose

2.4 mg weekly

Weeks to maintenance

16 weeks

First maintenance dose

Nov 28, 2026

Week	Date range	Dose	Pen color	Notes
1	Aug 8, 2026 — Aug 14, 2026	0.25 mg weekly	Light blue	Starting dose — dose-escalation phase
2	Aug 15, 2026 — Aug 21, 2026	0.25 mg weekly	Light blue	Starting dose — dose-escalation phase
3	Aug 22, 2026 — Aug 28, 2026	0.25 mg weekly	Light blue	Starting dose — dose-escalation phase
4	Aug 29, 2026 — Sep 4, 2026	0.25 mg weekly	Light blue	Starting dose — dose-escalation phase
5	Sep 5, 2026 — Sep 11, 2026	0.5 mg weekly	Red-violet
6	Sep 12, 2026 — Sep 18, 2026	0.5 mg weekly	Red-violet
7	Sep 19, 2026 — Sep 25, 2026	0.5 mg weekly	Red-violet
8	Sep 26, 2026 — Oct 2, 2026	0.5 mg weekly	Red-violet
9	Oct 3, 2026 — Oct 9, 2026	1 mg weekly	Yellow
10	Oct 10, 2026 — Oct 16, 2026	1 mg weekly	Yellow
11	Oct 17, 2026 — Oct 23, 2026	1 mg weekly	Yellow
12	Oct 24, 2026 — Oct 30, 2026	1 mg weekly	Yellow
13	Oct 31, 2026 — Nov 6, 2026	1.7 mg weekly	Teal
14	Nov 7, 2026 — Nov 13, 2026	1.7 mg weekly	Teal
15	Nov 14, 2026 — Nov 20, 2026	1.7 mg weekly	Teal
16	Nov 21, 2026 — Nov 27, 2026	1.7 mg weekly	Teal
17	Nov 28, 2026 — Dec 4, 2026	2.4 mg weekly	Dark blue	MAINTENANCEMaintenance dose reached
18	Dec 5, 2026 — Dec 11, 2026	2.4 mg weekly	Dark blue	MAINTENANCEMaintenance dose reached
19	Dec 12, 2026 — Dec 18, 2026	2.4 mg weekly	Dark blue	MAINTENANCEMaintenance dose reached
20	Dec 19, 2026 — Dec 25, 2026	2.4 mg weekly	Dark blue	MAINTENANCEMaintenance dose reached

How the planner works

Every dose, duration, and pen color in this planner comes directly from the FDA Prescribing Information (PI) for each medication. The planner does not invent or modify doses — it generates a calendar view of the exact FDA-label protocol.

Wegovy (semaglutide) [1]: 16-week titration from 0.25 mg to 2.4 mg maintenance, in 4-week steps.
Ozempic (semaglutide) [2]: 4-week start at 0.25 mg, then 0.5 mg, with optional increases to 1.0 mg and 2.0 mg.
Zepbound / Mounjaro (tirzepatide) [3][4]: 16-week titration from 2.5 mg to 15 mg maximum, increasing by 2.5 mg every 4 weeks.
Foundayo (orforglipron) [5]: Daily oral tablet. 12-week titration from 3 mg to 36 mg maintenance.

Important warning

Your prescriber may adjust this schedule based on your tolerance. This is the standard FDA-label protocol. Do not change doses without medical guidance. If you are experiencing intolerable side effects at any dose level, contact your prescriber before your next scheduled increase — they may recommend staying at the current dose for additional weeks or reducing the dose.

What this planner does NOT do

It does not provide medical advice or replace a conversation with your prescriber.
It does not account for individual tolerance — the FDA labels include “as tolerated” language that your prescriber will apply to your situation.
It does not generate prescriptions or medication orders.
It does not track actual injection/pill dates — it shows the planned schedule for reference.

Important disclaimer

This planner is for educational purposes only and does not constitute medical advice or a prescription. The titration schedules shown are the standard FDA-label protocols. Your actual titration may differ based on your clinical response, tolerance, and your prescriber's judgment. Never adjust your medication dose without consulting your prescriber.

References

1.Novo Nordisk. Wegovy (semaglutide) injection, for subcutaneous use — Prescribing Information. Section 2.1: Recommended Dosage. FDA / Drugs@FDA. 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf
2.Novo Nordisk. Ozempic (semaglutide) injection, for subcutaneous use — Prescribing Information. Section 2.1. FDA / Drugs@FDA. 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209637s020lbl.pdf
3.Eli Lilly and Company. Zepbound (tirzepatide) injection, for subcutaneous use — Prescribing Information. Section 2.1. FDA / Drugs@FDA. 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215866s000lbl.pdf
4.Eli Lilly and Company. Mounjaro (tirzepatide) injection, for subcutaneous use — Prescribing Information. Section 2.1. FDA / Drugs@FDA. 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866Orig1s000lbl.pdf
5.Eli Lilly and Company. Foundayo (orforglipron) tablets — Prescribing Information. FDA / Drugs@FDA. 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218226s000lbl.pdf

Related tools and research

GLP-1 Dose Plotter — visualize your dose history over time
GLP-1 Unit Converter — convert between mg, mL, and units
GLP-1 Missed Dose Guide — what to do if you miss a dose during titration
GLP-1 Weight Loss Calculator — week-by-week weight loss projections
Switching between GLP-1 medications — what happens to titration when you switch drugs
Semaglutide side effects: what to expect — the GI side effects that may affect titration pace
Side-effect timeline tool — when each side effect peaks and resolves, by drug and week. Slower titration shifts the peak; this tool shows what you avoid.